Tokyo Boeki Medisys Inc. develops, sells, and maintains automated analyzers for use in clinical examinations in hospitals and medical testing institutions.
The company's flagship product, compact but high-quality and high-performance "BiOLiS 24i" series, is an incredibly versatile device, usable not only for blood and urine, but even soil component analysis. With a sales network stretching across more than 70 countries worldwide, the company has already sold more than 6,000 units, holding top share globally among desktop blood analyzers. In order to further expand sales in the global market, the company has developed a new model, "BiOLiS 30i," with further enhanced functions such as improved processing speed.
In April 2015, the company became the successor to the sales division of the group company Tokyo Boeki Machinery Ltd., realizing the unification of manufacturing and sales. Engineers with advanced expert knowledge, sales-service engineers who directly hear the concerns of customers, and all other employees work together to contribute to medical care and the health of people around the world through the development and sales of products equipped with the latest technology.